The FDA has approved Apple’s AirPods Pro 2 to be used as over-the-counter hearing aids, making them a more affordable option for the 30 million Americans with mild to moderate …
"treatment"
-
-
In a campaign rally in Tucson, Arizona, former President Donald Trump made a bold promise to eliminate taxes on overtime pay if re-elected in 2024. Speaking to an enthusiastic crowd …
-
HealthNews
New Prostate Cancer Drug ‘CDKI-73’ Shows Promise in Treating Aggressive Forms, Study Finds
A new study reveals that a drug called CDKI-73 may offer an effective treatment for aggressive, drug-resistant prostate cancer, providing hope to men affected by the disease. Prostate cancer is …
-
Breaking NewsElection 2024
ABC’s World News Tonight Shows 100% Positive Spin for Harris, 93% Negative for Trump: MRC
According to a recent Media Research Center (MRC) report, ABC News anchor David Muir’s coverage of Vice President Kamala Harris and former President Donald Trump has shown a stark difference …
-
A new study adds to the growing evidence that Parkinson’s disease, once believed to start in the brain, may begin in the gut. The research points to a possible connection …
-
Breaking NewsElection 2024News
Harris Attempts to Justify Policy Reversals in First Campaign Interview
Vice President Kamala Harris, the Democratic presidential nominee, sat down for her first interview since launching her campaign, appearing on CNN on August 29. During the interview, Harris defended her …
-
A new study shows that recreational drug users are three times more likely to experience repeated heart attacks or strokes compared to those who don’t use drugs. The study, conducted …
-
The first NIH-funded clinical trial has confirmed that service dogs significantly improve the lives of veterans with PTSD. Conducted by the University of Arizona in partnership with K9s For Warriors, …
-
A recent study by Australian health researchers predicts a sharp increase in male cancer cases and deaths worldwide by 2050. The number of male cancer cases is expected to rise …
-
The U.S. Food and Drug Administration (FDA) has approved a new blood test developed by Guardant Health to detect colorectal cancer. The test, named Shield, provides a less invasive and …